Fermenta Biotech Share Price
Small Cap | Pharmaceuticals and health care | BSE: 506414
₹243.95 1.85 (0.76 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 242.20
High (₹) 253.00
Low (₹) 242.10
Prev. Close (₹) 242.10
Volume 32,109
VWAP (₹) 222.61
ROCE (%) 3.89
Industry P/E 43.95
TTM P/E 20.33
P/B Ratio 2.47
Market Cap (₹) Cr.717.97
Dividend Yield (%)0.51
EPS (₹) -7.99
ROE-8.09%
Sales Growth (%) -4.08
Profit Growth (%)-55.17
Day Range
253.00253.00
52 Week Range
145.00449.00
Historical Returns
Returns (6M)
-12.72 %
Returns (1Y)
58.25 %
Returns (3Y)
5.02 %
Returns (5Y)
18.39 %
Returns (6M)
-12.72 %
Returns (1Y)
58.25 %
Returns (3Y)
5.02 %
Returns (5Y)
18.39 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with Low Debt
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 34.32
MFI 10.64
ATR 34.80
Commodity Channel Index -117.06
ROC125 -25.88
ROC21 -35.44
Williams %R -97.24
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 229.90 | 234.45 | 239.90 | 224.45 | 219.90 | 214.45 | 209.90 |
Week Ago | 272.06 | 275.63 | 281.16 | 266.53 | 262.96 | 257.43 | 253.86 |
Month Ago | 384.44 | 391.72 | 405.44 | 370.72 | 363.44 | 349.72 | 342.44 |
EMA & SMA
243.95
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 252.58
9 Day 264.30
10 Day 269.13
12 Day 288.20
14 Day 307.24
20 Day 323.97
26 Day 334.61
50 Day 360.83
100 Day 347.89
200 Day 288.20
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
EXCEL FINANCE AND INVESTMENTS | block | Sell | 01 Aug, 2024 | ₹255.95 | 4,05,000 | BSE |
KRISHAN PREMNARAYEN | block | Buy | 01 Aug, 2024 | ₹255.95 | 4,05,000 | BSE |
EXCEL FINANCE AND INVESTMENTS | bulk | Sell | 01 Aug, 2024 | ₹255.95 | 4,05,000 | BSE |
KRISHAN PREMNARAYEN | bulk | Buy | 01 Aug, 2024 | ₹255.95 | 4,05,000 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
29 Nov, 2024 | Prashant Nagre | Disposal | ₹348.60 | 11,000 | BSE |
27 Nov, 2024 | Prashant Nagre | Disposal | ₹328.43 | 67,000 | BSE |
01 Dec, 2021 | Rajeshwari Datla | Acquisition | ₹289.10 | 84,400 | BSE |
30 Nov, 2021 | Krishna Datla | Acquisition | ₹294.69 | 42,000 | BSE |
26 Nov, 2021 | Rajeshwari Datla | Acquisition | ₹279.15 | 1,700 | BSE |
24 Nov, 2021 | Anupama Datla Desai | Acquisition | ₹275.84 | 1,08,300 | BSE |
16 Mar, 2020 | RAJESHWARI DATLA | Disposal | ₹ | 49,110 | BSE |
16 Mar, 2020 | PREETI THAKKAR | Acquisition | ₹ | 49,110 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
27 May, 2024 | Rs.1.2500 per share(25%)Final Dividend | 06 Aug, 2024 | 06 Aug, 2024 |
29 May, 2023 | Rs.1.2500 per share(25%)Final Dividend | 22 Sept, 2023 | 22 Sept, 2023 |
20 May, 2022 | Rs.1.2500 per share(25%)Final Dividend | 04 Aug, 2022 | 05 Aug, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
06 Mar, 2025 | BSE India | Company has been honoured with \Pride of Maharashtra 2025 - Best Innovation of the Year Award in the Manufacturing Sector\ |
23 Feb, 2025 | BSE India | Revision in credit rating |
18 Feb, 2025 | BSE India | Investor meet on February 21, 2025 |
18 Feb, 2025 | BSE India | Intimation of Earnings Presentation for Quarter 3 of Financial year 2024-25 |
11 Feb, 2025 | BSE India | Intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 |
11 Feb, 2025 | BSE India | Press release |
11 Feb, 2025 | BSE India | Integrated filing (Financial) for quarter and nine months ended December 31, 2024 |
11 Feb, 2025 | BSE India | Unaudited financial results for the quarter and nine months ended December 31, 2024 |
11 Feb, 2025 | BSE India | Unaudited financial results for the quarter and nine months ended December 31, 2024 |
04 Feb, 2025 | BSE India | Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and nine months ended December 31, 2024. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 05 Feb, 2025 | 11 Feb, 2025 |
Quarterly Results | -- | 08 Nov, 2024 | 14 Nov, 2024 |
Quarterly Results | -- | 06 Aug, 2024 | 12 Aug, 2024 |
Audited Results & Final Dividend | -- | 21 May, 2024 | 27 May, 2024 |
Quarterly Results | -- | 05 Feb, 2024 | 12 Feb, 2024 |
Quarterly Results | -- | 31 Oct, 2023 | 08 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 11 Aug, 2023 |
Audited Results & Final Dividend | -- | 23 May, 2023 | 29 May, 2023 |
Quarterly Results | -- | 03 Feb, 2023 | 10 Feb, 2023 |
Quarterly Results | -- | 03 Nov, 2022 | 11 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Fermenta Biotech
Fermenta Biotech is a Public Limited Listed company incorporated on 01/05/1951 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1951PLC008485 and registration number is 008485. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 307.09 Cr. and Equity Capital is Rs. 14.44 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1951
Managing Director
Mr. Prashant Nagre
NSE Symbol
--
Fermenta Biotech Management
Name | Designation |
---|---|
Mr. Pradeep M Chandan | Chairman & Ind.Dire (Non-Exe) |
Mr. Krishna Datla | Exe.Vice Chairman & Whole Time Director |
Mr. Prashant Nagre | Managing Director |
Mr. Satish Varma | Executive Director |
Ms. Anupama Datla Desai | Executive Director |
Ms. Rajeshwari Datla | Non Executive Director |
Mr. Pramod Kasat | Ind. Non-Executive Director |
Ms. Rajashri Ojha | Ind. Non-Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Fermenta Biotech
What is the share price of Fermenta Biotech?
The share price of Fermenta Biotech on 13 Mar, 2025 is ₹ 243.95.
What is 52W high and 52W low share price of Fermenta Biotech?
The highest and lowest 52W share prices of Fermenta Biotech are ₹ 449.000 and ₹ 145.000
What is the market cap of Fermenta Biotech?
The market capitalization of Fermenta Biotech as of 13 Mar, 2025 is ₹ 717.97 Crores
What is the P/E ratio of Fermenta Biotech?
The current P/E ratio of Fermenta Biotech as of 13 Mar, 2025 is 43.95
What is the PB ratio of Fermenta Biotech?
The PB ratio of Fermenta Biotech as of 13 Mar, 2025 is 2.47
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)